-
McIlroy questions LIV stars 'value' as talk of PGA return builds
-
Honduras places 80% of country on El Nino drought alert
-
'Breakthrough' mRNA cancer drug curbs melanoma in large trial
-
Some of Meta's safety tools were 'designed to fail': witness
-
Many US Fed policymakers back interest rate hikes if inflation stays high
-
PSG Ligue 1 opener moved over state of Parc des Princes pitch
-
Robinson and Tongue star as Pakistan collapse in England opener
-
UK PM launches bid to help homeless, donating part of his wages
-
All Blacks must get 'everything right' to beat Springboks, says legend Fitzpatrick
-
Golden Shoe winner Kane hopes for Ballon d'Or after 'best season ever'
-
Robinson and Tongue star as Pakistan all out for 171 in England opener
-
Kyiv's ex-defence chief makes risky bet by venturing into electoral grounds
-
Lake Zurich sees water level hit record low amid drought
-
Coventry have survival inspiration says Lampard
-
Merck and Moderna's tailored cancer drug curbs melanoma recurrence in trial
-
Reijnders leaves Man City for Saudi's Al Qadsiah
-
Referees chief Webb wants clamp-down on Premier League set-piece grappling
-
Trump says will meet North Korea's Kim later this year
-
Robinson makes history as Pakistan collapse against England
-
Stocks waver, dollar drops as US Treasury moves to lower bond yields
-
Alvarez can win back Atletico fans in two games: club chief
-
France recalls rare disease drug Tavneos after deaths
-
Oldest human brain cells grown in lab 'recorded passage of time'
-
Arsenal agree to sign Villa defender Konsa: reports
-
7,300 excess deaths and counting in France's historically hot summer
-
Evacuation orders lifted in Belgian wildfire zone
-
Ukraine MPs approve new defence minister after divisive reshuffle
-
UK media skewered for 'hounding' black academic
-
North Korea leader's sister says 'unaware' of reported Kim-Trump communication
-
More than 7,300 excess deaths in France's historically hot summer so far
-
Russia, Ukraine exchange 103 captured soldiers each
-
US socialists score shock Florida win as Trump picks stumble
-
Sainz signs new contract with F1 team Williams
-
Iran warns Gulf countries against helping US after UAE cuts trade ties
-
Playing at Real Madrid 'not for everyone': Bernardo Silva
-
Senior FIFA official withdraws support from embattled Infantino
-
As election nears, Israelis fear polarisation could spark violence
-
Lawson replaces injured Hadjar for Red Bull at Dutch GP
-
Bayern's Hoeness 'speechless' after second Musiala collapse
-
Robots sort packages and serve fast food at Beijing showcase
-
Reijnders leaves Man City for Saudi's Al Qadsiah: source
-
Leeds sign Swiss defender Elvedi from Monchengladbach
-
Arsenal chief expects Arteta to sign new contract 'very shortly'
-
Robinson double rocks Pakistan in first Test before rain stops play
-
Oil rises, stocks waver amid tech sell-off
-
Queen Camilla says was 'difficult' keeping King Charles' cancer private
-
Belgian fire of the century 'encircled' but fight goes on
-
UK PM launches bid to get rough sleepers off streets by Christmas
-
Japan target record medal haul at home Asian Games
-
England bowl against Pakistan in first Test of post-Bazball era
Bexil Corporation Announces 2026 Tender Offer
WALPOLE, NH / ACCESS Newswire / April 22, 2026 / Bexil Corporation (OTCID:BXLC) ("Bexil" or the "Company") today announced that it invites its stockholders to tender for $53.25 per share of the Company's common stock up to an aggregate of 40,000 shares. Stockholders may participate in the offer by tendering any or all of their shares, subject to the proration provisions and other limitations of the offer, as described in the offer to purchase. The offer to purchase and withdrawal rights will expire on June 16, 2026 at 5:00 p.m. ET unless the offer to purchase is extended or earlier terminated.
The offer to purchase and other tender offer materials are being furnished to stockholders of the Company and also may be obtained at www.Bexil.com. With questions or requests for assistance please call the Company at 212-785-0900 or write to Bexil Corporation, P.O. Box 4, Walpole, NH 03608, Attn: Secretary. Stockholders may also contact the broker, dealer, commercial bank, or trust company who holds their shares for assistance concerning the offer.
The Company's board of directors has approved the offer. However, neither the Company nor the board of directors makes any recommendation as to whether a stockholder should tender or refrain from tendering his or her shares, and neither the Company nor the board of directors has authorized any person to make any such recommendation. Stockholders are urged to evaluate carefully all information contained in the offer to purchase, consult their own investment and tax advisors, and make their own decision whether to tender shares and, if so, how many shares to tender.
THIS ANNOUNCEMENT IS FOR INFORMATIONAL PURPOSES ONLY. THIS ANNOUNCEMENT IS NOT AN OFFER TO PURCHASE OR A SOLICITATION OF AN OFFER TO PURCHASE ANY SHARES OF THE COMPANY'S COMMON STOCK. THE TENDER OFFER IS BEING MADE SOLELY PURSUANT TO THE OFFER TO PURCHASE AND RELATED DOCUMENTS. THE TENDER OFFER IS NOT BEING MADE IN ANY JURISDICTION IN WHICH THE MAKING OR ACCEPTANCE THEREOF WOULD NOT BE IN COMPLIANCE WITH THE SECURITIES, BLUE SKY OR OTHER LAWS OF SUCH JURISDICTION.
About Bexil Corporation
The objective of Bexil, a holding company, is to increase book value per share over time for the benefit of its stockholders. The Company is primarily engaged through a wholly owned subsidiary, Bexil Advisers LLC, in investment management. Bexil Advisers is a registered investment adviser and the investment manager to Bexil Investment Trust, a closed end fund (Stock Symbol: BXSY) (NAV Symbol: XBXIX). To learn more about Bexil please visit www.Bexil.com.
Safe Harbor Note
This release may contain certain "forward looking statements" within the meaning of federal securities laws including, but not limited to the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Bexil, which may cause the Company's actual results to be materially different from those expressed or implied by such statements. The Company may also make additional forward looking statements from time to time. All such subsequent forward looking statements, whether written or oral, by the Company or on its behalf, are also expressly qualified by these cautionary statements. Investors should carefully consider the risks, uncertainties, and other factors, together with the information included in the Company's Annual Report, at https://www.bexil.com/communications/cautionary-language, and similar information. All forward looking statements made herein are only made as of the date of this release, and the Company undertakes no obligation to publicly update such forward looking statements to reflect subsequent events or circumstances.
The Company views book value per share, a non-GAAP financial measure, as an important indicator of financial performance. Presented in conjunction with other financial information, the combined presentation can enhance an investor's understanding of the Company's underlying financial condition and results from operations. The definition of book value as presented in this press release is stockholders' equity attributable to Bexil stockholders divided by currently issued and outstanding shares.
Contact: Thomas O'Malley
Chief Financial Officer
212-785-0900
Email Contact
www.Bexil.com
SOURCE: Bexil Corporation
View the original press release on ACCESS Newswire
T.Perez--AT